Evaluation of biological activity of bone morphogenetic proteins on exposure to commonly used electrospinning solvents

Journal of Bioactive and Compatible Polymers

Volumn 26, Issue 6, 2011, Pages 578-589

  Madurantakam, Parthasarathy A ^a,b   Rodriguez, Isaac A ^a   Beckman, Matthew J ^c   Simpson, David G ^c   Bowlin, Gary L ^a  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

bone morphogenetic proteins (BMPs); bone tissue engineering; electrospinning; heterodimeric BMP 2 7; luciferase; organic solvents; slot blot assay

Indexed keywords

AQUEOUS BUFFER; BIOLOGICALLY ACTIVE MOLECULES; BONE MORPHOGENETIC PROTEINS; BONE SCAFFOLDS; BONE SUBSTITUTES; BONE TISSUE ENGINEERING; DELETERIOUS EFFECTS; ELECTROSPINNING PROCESS; HETERODIMERIC BMP-2/7; LUCIFERASE; MYOBLASTS; NANOFIBROUS SCAFFOLDS; RECENT TRENDS; RESPONSE ELEMENTS; SCAFFOLD FABRICATION;

BIOACTIVITY; BONE; ELECTROSPINNING; MOLECULAR BIOLOGY; MOLECULES; ORGANIC SOLVENTS; PROTEINS; SOLVENTS; STEM CELLS; THERMOGRAPHY (IMAGING); TISSUE;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BUFFER; LUCIFERASE; ORGANIC SOLVENT; OSTEOGENIC PROTEIN 1; TISSUE SCAFFOLD;

AQUEOUS SOLUTION; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ELECTROSPINNING; EXPOSURE; INFRARED SPECTROSCOPY; MYOBLAST; POLARIZATION; SOLVENT EFFECT; TISSUE ENGINEERING;

EID: 81555207221     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911511424012     Document Type: Article

References (30)

1. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J. 2001 ; 10: S96 - S101
2. Rengachary SS. Bone morphogenetic proteins: basic concepts. Neurosurg Focus. 2002 ; 13 (6). e2
3. Schmidmaier GP, Schwabe C Strobel, Wildemann B. Carrier systems and application of growth factors in orthopaedics. Injury. 2008 ; 39: S37 - S43
4. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996 ; 10 (13). 1580-1594 (Pubitemid 26268864)
5. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA, et al. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors. 1996 ; 13 (3-4). 291-300 (Pubitemid 26378947)
6. Zilberberg L, Dijke P ten, Sakai LY, Rifkin DB. A rapid and sensitive bioassay to measure bone morphogenetic protein activity. BMC Cell Biol. 2007 ; 8: 41
7. Reddi AH. Morphogenetic messages are in the extracellular matrix: biotechnology from bench to bedside. Biochem Soc Trans. 2000 ; 28 (4). 345-349
8. Volpato ZF, Lopes S, Ramos F, Motta A, Migliaresi C. Physical and in vitro biological evaluation of a PA6/MWCNT electrospun composite for biomedical applications. J Bioact Compat Polym. 2011 ; 26 (1). 35-47
9. Zhang H, Chen Z. Fabrication and characterization of electrospun PLGA/MWNTs/hydroxyapatite biocomposite scaffolds for bone tissue engineering. J Bioact Compat Polym. 2010 ; 25 (3). 241-259
10. Zhang H. Effects of electrospinning parameters on morphology and diameter of electrospun PLGA/MWNTs fibers. J Bioact Compat Polym. 2011 ; 26 (6). 590-606
11. Marie PJ. Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys. 2008 ; 473 (2). 98-105
12. Trubiani O, Fulle S, Traini T, Paludi M, la Rovere R, Orciani M, et al. Functional assay, expression of growth factors and proteins modulating bone-arrangement in human osteoblasts seeded on an anorganic bovine bone biomaterial. Eur Cell Mater. 2010 ; 20: 72-83
13. Laflamme C, Curt S, Rouabhia M. Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Arch Oral Biol. 2010 ; 55: 689-701
14. Guarino V, Alvarez-Perez M, Cirillo V, Ambrosio L. HMSC interaction with PCL and PCL/gelatin platforms: a comparative study on films and electrospun membranes. J Bioact Compat Polym. 2011 ; 26 (2). 144-160
15. Kato M, Toyoda H, Namikawa T, Hoshino M, Terai H, Miyamoto S, et al. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials. 2006 ; 27 (9). 2035-2041 (Pubitemid 41759497)
16. Saito N, Murakami N, Takahashi J, Horiuchi H, Ota H, Kato H, et al. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv Drug Deliv Rev. 2005 ; 57 (7). 1037-1048 (Pubitemid 40692290)
17. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M. Biodegradable poly(d, l-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res. 2001 ; 58 (4). 449-455 (Pubitemid 32643194)
18. Schmidmaier G, Wildemann B, Lubberstedt M, Haas NP, Raschke M. IGF-I and TGF-beta 1 incorporated in a poly(d,l-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture. J Biomed Mater Res B Appl Biomater. 2003 ; 65 (1). 157-162 (Pubitemid 37521388)
19. Wildemann B, Lubberstedt M, Haas NP, Raschke M, Schmidmaier G. IGF-I and TGF-beta 1 incorporated in a poly(d,l-lactide) implant coating maintain their activity over long-term storage-cell culture studies on primary human osteoblast-like cells. Biomaterials. 2004 ; 25 (17). 3639-3644 (Pubitemid 38327052)
20. Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, et al. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor beta-1) from a biodegradable poly(d, l-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone. 2001 ; 28 (4). 341-350 (Pubitemid 32390106)
21. Lamberg A, Schmidmaier GK Soballe, Elmengaard B. Locally delivered TGF-beta 1 and IGF-1 enhance the fixation of titanium implants: a study in dogs. Acta Orthop. 2006 ; 77 (5). 799-805 (Pubitemid 44521923)
22. Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone. 2002 ; 30 (6). 816-822 (Pubitemid 34616007)
23. Pauly S, Luttosch F, Morawski M, Haas NP, Schmidmaier G, Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone. 2009 ; 45 (3). 505-511
24. Wildemann B, Burkhardt N, Luebberstedt M, Vordemvenne T, Schmidmaier G. Proliferating and differentiating effects of three different growth factors on pluripotent mesenchymal cells and osteoblast like cells. J Orthop Surg Res. 2007 ; 2: 27
25. Schofer MD, Fuchs-Winkelmann S, Grabedunkel C, Wack C, Dersch R, Rudisile M, et al. Influence of poly(l-lactic acid) nanofibers and BMP-2-containing poly(l-lactic acid) nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells. ScientificWorldJournal. 2008 ; 8: 1269-1279
26. Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials. 2006 ; 27 (16). 3115-3124 (Pubitemid 43247585)
27. Fu YC, Nie H, Ho ML, Wang CK, Wang CH. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol Bioeng. 2008 ; 99 (4). 996-1006 (Pubitemid 351316641)
28. Nie H, Soh BW, Fu YC, Wang CH. Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng. 2008 ; 99 (1). 223-234
29. Yang Y, Li X, Qi M, Zhou S, Weng J. Release pattern and structural integrity of lysozyme encapsulated in core-sheath structured poly(dl-lactide) ultrafine fibers prepared by emulsion electrospinning. Eur J Pharm Biopharm. 2008 ; 69 (1). 106-116
30. Li X, Su Y, Liu S, Tan L, Mo X, Ramakrishna S. Encapsulation of proteins in poly(l-lactide-co-caprolactone) fibers by emulsion electrospinning. Colloids Surf B Biointerfaces. 2010 ; 75 (2). 418-424